© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
letters to the editor |
Sorafenib is active on lung metastases from synovial sarcoma
| The first 10% of the full text of this article appears below. |
We report on the case of a 46-year-old male who underwent resection of a monophasic synovial sarcoma (SS) of the left thigh followed by local radiotherapy in 2005. Soon after, he developed a local relapse plus bilateral lung metastases and underwent systemic chemotherapy (epirubicin plus ifosfamide), hyperthermic
1 Department of Medical Oncology, Istituto Oncologico Veneto-IOV IRCCS, Padua
2 Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Rozzano, Milan, Italy
* (E-mail: u.basso@tin.it)